share_log

Morgan Stanley Upgrades Centessa Pharmaceuticals to Equal-Weight, Raises Price Target to $8

Benzinga ·  Oct 26, 2023 05:07

Morgan Stanley analyst Matthew Harrison upgrades Centessa Pharmaceuticals (NASDAQ:CNTA) from Underweight to Equal-Weight and raises the price target from $4 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment